PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required
This Funding Opportunity Announcement (FOA), issued by the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA), invites eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) grant applications. United States SBCs that have the research capabilities and technological expertise to contribute to the R and D mission(s) of the NIH, CDC, and FDA awarding components identified in this FOA are encouraged to submit SBIR grant applications in response to identified topics (see PHS 2019-2 SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, and FDA.
This Parent Funding Opportunity Announcement requires that at least 1 clinical trial be proposed. The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions.
Funding Opportunity Details
NOT-OD-20-099; NOT-OD-20-091; NOT-MH-20-035; NOT-MH-20-013; NOT-MH-20-023; NOT-MH-20-020; NOT-MH-20-024; NOT-MH-20-019; NOT-OD-20-080; NOT-HD-19-035; NOT-DK-20-002; NOT-DK-20-001; NOT-DK-19-022; NOT-OD-19-137; NOT-OD-19-128; NOT-AT-19-025; NOT-OD-19-127; NOT-OD-19-105
Standard dates apply, by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.